Each pre-filled syringe contains Semaglutide INN 1.7 mg in 0.75 ml solution for injection. Fitaro is a glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence similarity to human GLP-1. It selectively binds to and activates the GLP-1 receptor, mimicking the action of incretin hormones to regulate appetite, stimulate glucose-dependent insulin secretion, suppress glucagon secretion, slow gastric emptying, and enhance satiety.